In glioblastoma (GBM), p300 catalyzes lactate-driven histone lactylation in the promoter region of interleukin 10 (IL-10), increasing IL-10 expression, which inhibits T-cell activity and facilitates tumor immune escape [51]. Here, EP300 is linked to glioblastoma.